Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2020
Sutro Biopharma prices $126 million public offering
Sutro Biopharma announced the pricing of an underwritten public offering of 6 million common shares at $21 per share. The offering was expected to close on or about December 11, subject to customary closing conditions.
2020
Sutro Biopharma promotes two executives to vice president roles
Sutro Biopharma announced the promotions of Carlos Lugo to Vice President of Quality and CMC Regulatory Operations and Devendra Luhar to Vice President of Manufacturing & Plant Operations.
2020
Sutro Biopharma appoints James Panek to its board
Sutro Biopharma announced the appointment of James P. Panek to its Board of Directors on January 8, 2020.